Adicet

formerly Adicet BioIPO

Gamma Delta T cells | Off the-shelf T cell therapy

Redwood City, United States · Founded 2014 · $131.0M raised

Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$131.0M
Last Round
$80.0M Series BOct 2019
Rounds
2

About

Adicet Bio is a clinical-stage biotech developing off-the-shelf allogeneic gamma delta T cell therapies for cancer and autoimmune diseases. Founded in 2014 and headquartered in Redwood City, CA, with offices in Boston and Shanghai.

Summary

Adicet is a Biotech company based in Redwood City, United States, founded in 2014. It has raised $131.0M in total across 2 rounds, most recently a $80.0M Series B round in Oct 2019. Investors include OrbiMed, Novartis Venture Fund and Pontifax.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BOct 2019
$80.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Adicet on Indexed.vc
<a href="https://indexed.vc/companies/adicet"><img src="https://indexed.vc/api/badge/company/adicet" alt="Adicet on Indexed.vc" width="260" height="76" /></a>